Atypical primary malignant melanoma originating in the spinal canal: A case report and literature review

被引:0
作者
Zeng, Ying [1 ]
Zhang, Yong [1 ]
Zhang, Jing [1 ]
Jian, Wei [1 ]
Li, Rongqing [1 ,2 ]
Fu, Qiaofen [1 ,2 ]
机构
[1] Kunming Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Kunming 650032, Yunnan, Peoples R China
[2] Kunming Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China
关键词
spinal cord; central nervous system; primary melanoma; radiotherapy; chemotherapy; bevacizumab; CENTRAL-NERVOUS-SYSTEM; INTRACRANIAL MELANOMA; BEVACIZUMAB; METASTASES; SCHWANNOMA; TUMOR; FOCUS;
D O I
10.3892/ol.2023.14020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Central nervous system (CNS) malignant melanomas are rare tumors of the CNS that are thought to arise from aberrant changes in melanocytes of the neural crest or melanocytic elements of the pia mater during early embryonic development. As a rare type of CNS malignant melanoma, only a few cases of primary malignant melanoma in the spinal canal have been reported thus far. The majority of these studies have reported on the diagnosis, radiographic features and gross total resection of primary spinal canal malignant melanoma; however, the prognosis and ideal treatment of patients with residual tumors remain elusive. The current study presented the rare case of a patient with primary malignant melanoma originating from the thoracic spinal canal, without any history of irradiation exposure and with an incompletely resected tumor. Disease-free survival of >2.5 years was observed in this patient who was treated with concurrent chemoradiotherapy followed by adjuvant chemotherapy with temozolomide and bevacizumab.
引用
收藏
页数:6
相关论文
共 42 条
[1]   The Interplay between Tumour Microenvironment Components in Malignant Melanoma [J].
Amalinei, Cornelia ;
Grigoras, Adriana ;
Lozneanu, Ludmila ;
Caruntu, Irina-Draga ;
Giusca, Simona-Eliza ;
Balan, Raluca Anca .
MEDICINA-LITHUANIA, 2022, 58 (03)
[2]   Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial [J].
Ascierto, Paolo A. A. ;
Mandala, Mario ;
Ferrucci, Pier Francesso ;
Guidoboni, Massimo ;
Rutkowski, Piotr ;
Ferraresi, Virginia ;
Arance, Ana ;
Guida, Michele ;
Maiello, Evaristo ;
Gogas, Helen ;
Richtig, Erika ;
Fierro, Maria Teresa ;
Lebbe, Celeste ;
Helgadottir, Hildur ;
Queirolo, Paola ;
Spagnolo, Francesco ;
Tucci, Marco ;
Del Vecchio, Michele ;
Gonzales Cao, Maria ;
Minisini, Alessandro Marco ;
De Placido, Sabino ;
Sanmamed, Miguel F. F. ;
Mallardo, Domenico ;
Curvietto, Marcello ;
Melero, Ignacio ;
Palmieri, Giuseppe ;
Grimaldi, Antonio M. ;
Giannarelli, Diana ;
Dummer, Reinhard ;
Sileni, Vanna Chiarion .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) :212-+
[3]   PRIMARY SOLITARY INTRACRANIAL MELANOMA - CASE-REPORT AND REVIEW OF THE LITERATURE [J].
BAENA, RRY ;
GAETANI, P ;
DANOVA, M ;
BOSI, F ;
ZAPPOLI, F .
SURGICAL NEUROLOGY, 1992, 38 (01) :26-37
[4]   The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers [J].
Bai, Xuexue ;
Zhou, Meng .
FRONTIERS IN ONCOLOGY, 2022, 12
[5]   Primary Intracranial Melanoma with Early Leptomeningeal Spread: A Case Report and Treatment Options Available [J].
Balakrishnan, Rajesh ;
Porag, Rokeya ;
Asif, Dewan Shamsul ;
Satter, A. M. Rejaus ;
Taufiq, Md. ;
Gaddam, Samson S. K. .
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
[6]   Bevacizumab as a steroid-sparing agent during immunotherapy for melanoma brain metastases: A case series [J].
Banks, Patricia D. ;
Lasocki, Arian ;
Lau, Peter K. H. ;
Sandhu, Shahneen ;
McArthur, Grant ;
Shackleton, Mark .
HEALTH SCIENCE REPORTS, 2019, 2 (03)
[8]  
Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO
[9]  
2-G
[10]   Central nervous system metastases of cutaneous malignant melanoma -: A population-based study [J].
Cohn-Cedermark, G ;
Månsson-Brahme, E ;
Rutqvist, LE ;
Larsson, O ;
Johansson, H ;
Ringborg, U .
ACTA ONCOLOGICA, 1998, 37 (05) :463-470